Respiratory Viruses

InPheno is dedicated to developing and advancing the discovery and development of new antivirals to fight off major causes of respiratory tract infections. The assays we offer are monitoring the inhibition of plaque formation or virus-induced cytopathic effects (CPE). These assays can also be used to survey the antibody response in vaccinees or to select neutralizing monoclonal antibodies.

Influenza
InPheno’s assays run with either type A or B influenza virus; they also accommodate clinical isolates e.g., those resistant to approved neuraminidase inhibitors.

Respiratory Syncytial Virus and Parainfluenza Virus
In addition to assays using live viruses, InPheno is currently developing entry and replicon-based assays for RSV and PIV.

For more information or to discuss respiratory viruses please contact us directly.